Role of activin-A in cigarette smoke-induced inflammation and COPD

European Respiratory Journal

Volumn 43, Issue 4, 2014, Pages 1028-1041

  Verhamme, Fien M ^a   Bracke, Ken R ^a   Amatngalim, Gimano D ^b   Verleden, Geert M ^c   Van Pottelberge, Geert R ^a   Hiemstra, Pieter S ^b   Joos, Guy F ^a   Brusselle, Guy G ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; CIGARETTE SMOKE; FOLLISTATIN; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA; ACTIVIN; SMOKE;

ADULT; AGED; ANIMAL EXPERIMENT; ASTHMA; BRONCHUS MUCOSA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INFLAMMATORY CELL; LUNG FIBROSIS; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; C57BL MOUSE; CELL CULTURE; DRUG EFFECTS; LUNG; METABOLISM; PHYSIOLOGY; SMOKE; SMOKING;

ACTIVINS; ANIMALS; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FOLLISTATIN; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LUNG; MICE; MICE, INBRED C57BL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SMOKE; SMOKING;

EID: 84897457261     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00082413     Document Type: Conference Paper

References (44)

1. Vestbo J, Hurd SS, Agusti A.G., et al Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease GOLD Executive Summary. Am J Respir Crit Care Med 2013; 187: 347-365.
2. Murray CJ, Lopez AD Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997; 349: 1498-1504.
3. Brusselle GG, Joos GF, Bracke KR New insights into the immunology of chronic obstructive pulmonary disease. Lancet 2011; 378: 1015-1026.
4. Demedts I, Demoor T, Bracke K.R., et al Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema. Respir Res 2006; 7: 53.
5. Kim V, Rogers TJ, Criner GJ New concepts in the pathobiology of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008; 5: 478-485.
6. Blobe GC, Schiemann WP, Lodish HF Role of transforming growth factor-β in human disease. N Engl J Med 2000; 342: 1350-1358.
7. Boer WI, van Schadewijk A, Sont JK, et al Transforming growth factor-β1 and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158: 1951-1957.
8. Li MO, Wan YY, Sanjabi S, et al Transforming growth factor-β regulation of immune responses. Annu Rev Immunol 2006; 24: 99-146.
9. Takizawa H, Tanaka M, Takami K., et al Increased expression of transforming growth factor-β1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med 2001; 163: 1476-1483.
10. Abe Y, Minegishi T, Leung PCK. Activin receptor signaling. Growth Factors 2004; 22: 105-110.
11. Dijke P, Hill CS New insights into TGF-β-Smad signalling. Trends Biochem Sci 2004; 29: 265-273.
12. Harrison CA, Gray PC, Vale W.W., et al Antagonists of activin signaling: mechanisms and potential biological applications. Trends Endocrinol Metab 2005; 16: 73-78.
13. Glister C, Kemp CF, Knight PG Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4,-6 and-7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin. Reproduction 2004; 127: 239-254.
14. Nogai H, Rosowski M, Grun J., et al Follistatin antagonizes transforming growth factor-β3-induced epithelialmesenchymal transition in vitro: implications for murine palatal development supported by microarray analysis. Differentiation 2008; 76: 404-416.
15. Hardy CL, O'Connor AE, Yao J, et al Follistatin is a candidate endogenous negative regulator of activin A in experimental allergic asthma. Clin Exp Allergy 2006; 36: 941-950.
16. Karagiannidis C, Hense G, Martin C., et al Activin A is an acute allergen-responsive cytokine and provides a link to TGF-β-mediated airway remodeling in asthma. J Allergy Clin Immunol 2006; 117: 111-118.
17. Kariyawasam HH, Pegorier S, Barkans J., et al Activin and transforming growth factor-beta signaling pathways are activated after allergen challenge in mild asthma. J Allergy Clin Immunol 2009; 124: 454-462.
18. Rosendahl A, Checchin D, Fehniger T.E., et al Activation of the TGF-β/activin-Smad2 pathway during allergic airway inflammation. Am J Respir Cell Mol Biol 2001; 25: 60-68.
19. Apostolou E, Stavropoulos A, Sountoulidis A., et al Activin-A overexpression in the murine lung causes pathology that simulates acute respiratory distress syndrome. Am J Respir Crit Care Med 2012; 185: 382-391.
20. Matsuse T, Ikegami A, Ohga E., et al Expression of immunoreactive activin a protein in remodeling lesions associated with interstitial pulmonary fibrosis. Am J Pathol 1996; 148: 707-713.
21. Pottelberge GR, Bracke KR, Demedts I.K., et al Selective accumulation of langerhans-type dendritic cells in small airways of patients with COPD. Respir Res 2010; 11: 35.
22. Wetering S, van der Linden AC, van Sterkenburg MAJA, et al. Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase. J Investig Med 2000; 48: 359-366.
23. Zuyderduyn S, Ninaber D, Schrumpf J., et al IL-4 and IL-13 exposure during mucociliary differentiation of bronchial epithelial cells increases antimicrobial activity and expression of antimicrobial peptides. Respir Res 2011; 12: 59.
24. Beisswenger C, Platz J, Seifart C., et al Exposure of differentiated airway epithelial cells to volatile smoke in vitro. Respiration 2004; 71: 402-409.
25. D'hulst A.I., Vermaelen KY, Brusselle G.G., et al Time course of cigarette smoke-induced pulmonary inflammation in mice. Eur Respir J 2005; 26: 204-213.
26. Zhang YQ, Resta S, Jung B., et al Upregulation of activin signaling in experimental colitis. Am J Physiol Gastrointest Liver Physiol 2009; 297: G768-G780.
27. Hubner G. Activin A: A novel player and inflammatory marker in inflammatory bowel disease? Lab Invest 1997; 77: 311-318.
28. Ota F. Activin a induces cell proliferation of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Rheum 2003; 48: 2442-2449.
29. DiChiara MR, Kiely JM, Gimbrone M.A., et al Inhibition of E-selectin gene expression by transforming growth factor-β in endothelial cells involves coactivator integration of Smad and nuclear factor KB-mediated signals. J Exp Med 2000; 192: 695-704.
30. Maunders H, Patwardhan S, Phillips J., et al Human bronchial epithelial cell transcriptome: gene expression changes following acute exposure to whole cigarette smoke in vitro. Am J Physiol Lung Cell Mol Physiol 2007; 292: L1248-L1256.
31. Leigh R, Oyelusi W, Wiehler S., et al Human rhinovirus infection enhances airway epithelial cell production of growth factors involved in airway remodeling. J Allergy Clin Immunol 2008; 121: 1238-1245.
32. Saetta M, Di Stefano A, Turato G, et al CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 822-826.
33. Demoor T, Bracke KR, Joos G.F., et al Increased T-regulatory cells in lungs and draining lymph nodes in a murine model of COPD. Eur Respir J 2010; 35: 688-689.
34. Aoki F, Kurabayashi M, Hasegawa Y., et al Attenuation of bleomycin-induced pulmonary fibrosis by follistatin. Am J Respir Crit Care Med 2005; 172: 713-720.
35. Apostolou E, Stavropoulos A, Sountoulidis A., et al Activin-A overexpression in the murine lung causes pathology that simulates acute respiratory distress syndrome. Am J Respir Crit Care Med 2012; 185: 382-391.
36. Semitekolou M, Alissafi T, Aggelakopoulou M., et al Activin-A induces regulatory T cells that suppress T helper cell immune responses and protect from allergic airway disease. J Exp Med 2009; 206: 1769-1785.
37. Phillips DJ, de Kretser DM, Hedger MP Activin and related proteins in inflammation: not just interested bystanders. Cytokine Growth Factor Rev 2009; 20: 153-164.
38. Sierra-Filardi E., Puig-Kröger A, Blanco FJ, et al. Activin A skews macrophage polarization by promoting a proinflammatory phenotype and inhibiting the acquisition of anti-inflammatory macrophage markers. Blood 2011; 117: 5092-5101.
39. Huber S, Stahl FR, Schrader J, et al. Activin A promotes the TGF-β-induced conversion of CD4+CD25-T Cells into Foxp3+ induced regulatory T cells. J Immunol 2009; 182: 4633-4640.
40. Hedger MP, Winnall WR, Phillips D.J., et al The regulation and functions of activin and follistatin in inflammation and immunity. Vitam Horm 2011; 85: 255-297.
41. Cho SH, Yao Z, Wang S.W., et al Regulation of activin A expression in mast cells and asthma: its effect on the proliferation of human airway smooth muscle cells. J Immunol 2003; 170: 4045-4052.
42. Ohga E, Matsuse T, Teramoto S., et al Effects of activin A on proliferation and differentiation of human lung fibroblasts. Biochem Biophys Res Commun 1996; 228: 391-396.
43. Gregory LG, Mathie SA, Walker S.A., et al Overexpression of smad2 drives house dust mite-mediated airway remodeling and airway hyperresponsiveness via activin and IL-25. Am J Respir Crit Care Med 2010; 182: 143-154.
44. Hardy CL, Nguyen HA, Mohamud R, et al The activin A antagonist follistatin inhibits asthmatic airway remodelling. Thorax 2013; 68: 9-18.